TITLE

Managing Medicare's HIV Caseload in the Era of Suppressive Therapy

AUTHOR(S)
Gilden, David E.; Kubisiak, Joanna M.; Gilden, Daniel M.
PUB. DATE
June 2007
SOURCE
American Journal of Public Health;Jun2007, Vol. 97 Issue 6, p1053
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives. The 1996 introduction of antiretroviral medications changed Medicare's role in providing HIV care. We analyzed Medicare's patient database in an effort to document the new HIV therapies' effects on expenditures and outcomes. Methods. We examined the medical billing records of a 5% national Medicare sample from 1997 through 2003. The cohort was stratified by year and categorized by age, race/ethnicity, gender, and Medicare status. Population summaries were categorized according to presence of major chronic diseases and HIV-related conditions. Results. The number of Medicare beneficiaries with HIV increased from 42520 in 1997 to 76500 in 2003, whereas mortality among this group fell by 35%. HIV-associated infections declined by as much as 43% (mycoses). Heart and liver disease and diabetes increased by more than 50%. Adjusted annual per person Medicare expenditures fell 28%; expenditures were 49% higher for Blacks than for Whites. Conclusions. Improved HIV medical management has led to fewer deaths and has shifted treatment toward chronic care. However, successful management is complicated by conditions that have not been historically linked to HIV and whose effects vary according to race/ethnicity. (Am J Public Health-2007;97:1053-1059. doi: 10.2105/AJ PH.2005.063636}
ACCESSION #
25302434

 

Related Articles

  • Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Torti, Carlo; Raffetti, Elena; Donato, Francesco; Castelli, Francesco; Maggiolo, Franco; Angarano, Gioacchino; Mazzotta, Francesco; Gori, Andrea; Sighinolfi, Laura; Pan, Angelo; Cauda, Roberto; Scalzini, Alfredo; Quiros-Roldan, Eugenia; Nasta, Paola; Gregis, Giampietro; Benatti, Simone; Digiambenedetto, Simona; Ladisa, Nicoletta; Giralda, Mariarosaria; Saracino, Annalisa // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p1 

    No abstract available.

  • Assessment of hematological adverse drug reactions to antiretroviral therapy in HIV positive patients at Kasturba Hospital Manipal. Pulagam, Poornima; Rajesh, Radhakrishnan; Vidyasagar, Sudha; Varma, Danturulu Muralidhar // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study on the hematological adverse drug reactions (ADRs) associated with highly active antiretroviral therapy in HIV positive patients in India. The authors investigate the casuality, incidence rate and severity pattern of hematological ADRs among HIV patients. The study...

  • Prevalence of depressive symptoms amongst highly active antiretroviral therapy (HAART) patients in AIDSRelief Uganda. Shumba, Constance; Atukunda, Ruth; Imakit, Richard; Memiah, Peter // Journal of Public Health in Africa;2013, Vol. 4 Issue 2, p84 

    There is limited data on the prevalence of depression in HIV and AIDS patients in Sub- Saharan Africa and little resources have been allocated to address this issue. Depression affects patient adherence to treatment and predisposes patients to resistance which poses a public health threat. It...

  • Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. Shigdel, Rajesh; Klouman, Elise; Bhandari, Anita; Ahmed, Luai A. // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p109 

    Purpose: There are a high number of HIV-infected patients receiving antiretroviral therapy (ART) in the Kathmandu District of Nepal, but information on adherence and factors influencing it are scarce in this population. The present study aimed to estimate ART adherence among HIV-infected...

  • Determinants of Mortality and Loss to Follow-Up among Adults Enrolled in HIV Care Services in Rwanda. Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Tayebwa, Edwin; Ingabire, Eugenie; Ingabire, Pacifique; Sahabo, Ruben; Twyman, Peter; Abrams, Elaine J. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rates of loss to follow-up (LTF) and mortality have been documented in HIV care and treatment programs. Methods: We analyzed routinely-collected data on HIV-infected patients ≥15...

  • Treatment for Adult HIV Infection. Hammer, Scott M.; Saag, Michael S.; Schechter, Mauro; Montaner, Julio S.G.; Schooley, Robert T.; Jacobsen, Donna M.; Thompson, Melanie A.; Carpenter, Charles C.J.; Fischl, Margaret A.; Gazzard, Brian G.; Gatell, Jose M.; Hirsch, Martin S.; Katzenstein, David A.; Richman, Douglas D.; Vella, Stefano; Yeni, Patrick G.; Volberding, Paul A. // JAMA: Journal of the American Medical Association;8/16/2006, Vol. 296 Issue 7, p827 

    Context Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. The International AIDS Society-USA panel has updated its recommendations as warranted by new developments in...

  • Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A Randomized Trial. Saag, Michael S.; Cahn, Pedro; Raffi, François; Wolff, Marcelo; Pearce, Daniel; Molina, Jean-Michel; Powderly, William; Shaw, Audrey L.; Mondou, Elsa; Hinkle, John; Borroto-Esoda, Katyna; Quinn, Joseph B.; Barry, David W.; Rousseau, Franck // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p180 

    Context Emtricitabine is a new, once-daily nucleoside reverse transcriptase inhibitor (NRTI) with potent activity against human immunodeficiency virus (HIV). Objective To assess the efficacy and safety of emtricitabine as compared with stavudine when used with a background regimen of didanosine...

  • Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A 3-Year Randomized Trial. Gallant, Joel E.; Staszewski, Schlomo; Pozniak, Anton L.; DeJesus, Edwin; Suleiman, Jamal M. A. H.; Miller, Michael D.; Coakley, Dion F.; Lu, Biao; Toole, John J.; Cheng, Andrew K. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p191 

    Context Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor. Objective To evaluate the efficacy and safety of tenofovir DF compared with stavudine in antiretroviral-naive patients. Design, Setting, and Participants A prospective, randomized,...

  • Treatment of HIV/AIDS: Do the Dilemmas Only Increase? Sande, Merle A.; Ronald, Allan // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p266 

    Presents an editorial on HIV/AIDS treatment and mentions articles in this issue of "JAMA". Guidelines set by the International AIDS Society-USA (IAS-USA) for HIV care reported in this issue; View that clinical trials using highly active antiretroviral therapy (HAART) should be redirected to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics